Arbutus Biopharma ABUS
NASDAQ ABUS
$3.91 +0.03 (+0.90%)
As of: Nov 12, 2026 · 11:17 AM EST

Arbutus Biopharma (ABUS) Return on Invested Capital [ROIC] (2017 - 2018)

Updated

Arbutus Biopharma (ABUS) recorded Return on Invested Capital [ROIC] of -23.17% in Q4 2018, up 0.78 percentage points from -23.95% a year earlier and up 19.36 percentage points from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Return on Invested Capital [ROIC] (2017 - 2018) Analysis & Trends

For FY2018, Arbutus Biopharma reported Return on Invested Capital [ROIC] of -42.32%, down 0.25 percentage points from FY2017.

  • Across earlier years, Return on Invested Capital [ROIC] came in at -42.06% in FY2017 (+59.19 pp) and -101.25% in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Arbutus Biopharma 758.95 Mn 142.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -23.17%
Sep 30, 2018 -42.53%
Dec 31, 2017 -23.95%
Sep 30, 2017 -145.86%
Jun 30, 2017 -107.67%
API Access

Arbutus Biopharma Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ABUS&period=max&api_key=YOUR_API_KEY